🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
Status
Withdrawn
Location
Multiple Locations
Start Date
2025-04-18
Trial ID
NCT06878833
Treatments Being Tested
International Observational Registry on Schizophrenia...
Status
Completed
Location
Multiple Locations
Start Date
2009-06
Trial ID
NCT01026285
Treatments Being Tested
This is an open-label, one sequence study to evaluate the steady-state comp...
Status
Completed
Location
Collaborative Neuroscience Network
Start Date
2018-07-09
Trial ID
NCT03527186
Treatments Being Tested
SchizOMICS is a Phase IV, multicenter, dose-flexible, open-label, randomize...
Status
Unknown
Location
Multiple Locations
Start Date
2023-11-01
Trial ID
NCT06060886
Treatments Being Tested
An inpatient/outpatient study to see if LY2140023 is better than placebo in...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Start Date
2010-03
Trial ID
NCT01086748
Treatments Being Tested
This trial examines the efficacy of cannabidiol (CBD) versus risperidone fo...
Status
Active Not Recruiting
Location
Center for Neuropsychiatric Schizophrenia Research
Start Date
2021-06-01
Trial ID
NCT04105231
Treatments Being Tested
The purpose of this study is to gather information about the steady-state p...
Status
Completed
Location
Multiple Locations
Start Date
2014-02
Trial ID
NCT02087579
The purpose of this study is to evaluate efficacy, safety and tolerance of ...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT01726335
Treatments Being Tested
This study will determine the effectiveness of oral risperidone versus long...
Status
Completed
Location
Semel Institute for Neuroscience and Human Behavior at UCLA
Start Date
2006-03
Trial ID
NCT00330551
Treatments Being Tested
In the proposed study 450 veterans with a primary diagnosis of schizophreni...
Status
Completed
Location
VA Medical Center, Tuscaloosa
Start Date
2006-09
Trial ID
NCT00132314
Treatments Being Tested